# Fulcrum Therapeutics, Inc.: Form 8-K, filed Mar 4, 2025

- Company: [Fulcrum Therapeutics, Inc.](/companies/fulc.md) (CIK 1680581)
- Form: 8-K
- Filed: 2025-03-04
- Accepted by EDGAR: Mar 4, 2025, 17:00 ET
- Period: 2025-02-26
- Accession: 0000950170-25-032355
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1680581/000095017025032355/fulc-20250226.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1680581/000095017025032355/

## Items reported

- Item 1.02: Termination of a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1680581/000095017025032355/fulc-20250226.htm

Filed Mar 4, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-032355. Last ingested by Listed: Nov 4, 2026, 17:36 ET. No prices; not investment advice.